Chinese Medicine (Feb 2022)

Mineral medicine: from traditional drugs to multifunctional delivery systems

  • Xiaoqing Zhong,
  • Zhenning Di,
  • Yuanxin Xu,
  • Qifan Liang,
  • Kuanhan Feng,
  • Yuting Zhang,
  • Liuqing Di,
  • Ruoning Wang

DOI
https://doi.org/10.1186/s13020-022-00577-9
Journal volume & issue
Vol. 17, no. 1
pp. 1 – 30

Abstract

Read online

Abstract Mineral drugs are an important constituent of traditional Chinese medicine (TCM). Taking minerals that contain heavy metals as drugs is a very national characteristic part of TCM. However, the safety and scientific nature of mineral drugs are controversial owing to their heavy metals and strong toxicity. In 2000, the Food and Drug Administration (FDA) authorized arsenic trioxide (ATO) as first-line therapy for acute promyelocytic leukemia. This makes the development and utilization of mineral drugs become a research hotspot. The development of nanomedicine has found a great prospect of mineral drugs in nano-delivery carriers. And that will hold promise to address the numerous biological barriers facing mineral drug formulations. However, the studies on mineral drugs in the delivery system are few at present. There is also a lack of a detailed description of mineral drug delivery systems. In this review, the advanced strategies of mineral drug delivery systems in tumor therapy are summarized. In addition, the therapeutic advantages and research progress of novel mineral drug delivery systems are also discussed. Here, we hope that this will provide a useful reference for the design and application of new mineral drug delivery systems. Graphical Abstract

Keywords